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Sinary 5-Aminolaevulinic acid (ALA)-induced porphyrin biosynthesis and phototoxicity in vitro was
investigated in five malignant and two normal cell lnes. Intracellular protoporphyrin IX (PpIX) content was
quantified by extraction and fluorescence spectroscopy. Cellular PpIX content did not always correlate with
cell proliferation rate as measured by the doubling times of cell lines. Celular efflux of PpIX was also
investigated. In a bladder carcinoma cell line, the observed rapid efflux was not blocked by verapamil, an
inhibitor of the P-glycoprotein efflux pump. These data support the view that cellular PpIX accumulation is a
dynamc process that is determned by both the efflux ofPpIX from the cells and enzyme activities in the haem
biosynthesis pathway. Desferrioxamine (desferal), a modulator of PpIX biosynthesis, enhanced ALA-induced
cellular PpIX content significantly in all carcinoma cell lines but not in non-malignant cell lines. The enhanced
PpIX cellular accumulation is attributed to inhibition of ferrochelatase activity, the enzyme responsible for the
conversion of PpIX to haem. PpIX-mediated cellular photodestruction following irradiation with an argon ion
laser at 514.5 nm was determined by the 'MTT assay'. There appeared to be a 'threshold' effect of cellular
PpIX content; cells that synthesise less than 140 ng Lgg' protein exhibited very little phototoxic damage,
while cell lines having greater than 140 ng PpIX pgg' protein exhibited a consistent phototoxic response.
Among the cell lines which did undergo phototoxic damage, there was not a strict correlation between PpIX
cellular content and ALA-induced phototoxicity. Desferal ancd the PpIX content and phototoxic effect in
the responsive cells. Fluorescence microscopy of the ALA-treated cells revealed marked accumulation of PpIX
in mitochondria (rhodamine 123 co-staining). That the primary site of phototoxic damage is also the
mitochondria was confirmed by eklctron micrographs of cells photosensitised with ALA-induced PpIX, which
showed swelling of mitochondria within minutes after irradiation while other suborganeles appeared to be
unaffected. The repair or further destruction of the mitochondria was fluence and cell-type dependent. The
data from this study suggest that the basis of increased ALA-induced PpIX accumulation in tumours is a
combination of various aspects of the metabolic process and pharmacokinetics and that the efficacy of
photodestruction of malignancy will be determined not only by the rate of PpIX synthesis but also by specific
cellular and tissue characteristics.
Photodynamic therapy (PDT) is an investigational strategy
for cancer therapy. It consists of the administration of an
exogenous photoactivatable compound that accumulates in
malignant and other tissues, followed by an adequate dose of
photoactivating light. Photofrin, a mixture of porphyrins, is
the photosensitiser that has been used in the majority of
clinical trials (Dougherty, 1987; Marcus, 1992). However,
prolonged skin photosensitivity due to non-specific localisa-
tion of the photosensitiser is associated with Photofrin-
mediated PDT (Benson, 1988). Therefore new photosensitisers
and better methods of photosensitiser localisation are being
investigated (Bachor et al., 1991; Goff et al., 1991; Gomer,
1991; Pandey et al., 1991; Hasan, 1992; Henderson &
Dougherty, 1992). Other approaches for achieving better
localisation include local administration of the photosen-
sitiser (Amano et al., 1988; Bachor et al., 1992). Recently,
there has been considerable interest in a different approach to
PDT in which a precursor, ALA, is administered and syn-
thesis of the photosensitiser, PpIX, accomplished in situ (Pot-
tier et al., 1986; Malik & Lugaci, 1987; Malik et al., 1989;
Divaris et al., 1990; Kennedy et al., 1990; Bedwell et al.,
1992; Kennedy & Pottier, 1992; Loh et al., 1992, 1993a,b;
Rebeiz et al., 1992). The synthesis of ALA is the rate-limiting
step in non-erythroid cells in the pathway of haem biosyn-
thesis (Martin, 1985) so that an increase in porphyrins is
expected if this rate-limiting step is bypassed by the addition
of exogenous ALA. From the viewpoint of PDT of tumours,
a potentially exploitable aspect of this approach is that
malignant cells, which often grow faster may, in principle,
produce more porphyrin than their slower growing normal
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counterparts, leading to an increased accumulation of PpIX
in these cells. A correlation between cell proliferation rates
and PpIX synthesis is suggested by observations that mitogen
stimulation of splenocytes increased PpIX accumulation
(Rebeiz et al., 1992). PpIX accumulation was also increased
in a metastatic variant of Eab lymphoma cells compared with
its non-metastatic counterpart (Malik et al., 1989), although
proliferation rates were not explicitly stated. However, except
for these two suggestive studies, a correlation of PpIX syn-
thesis with proliferation rates has not yet been investigated
systematically in diverse cell lines. Such a study might help
clarify the underlying reasons for the increased PpIX concen-
trations in tumours and have implications in optiising its
therapeutic effects. The goals of this study were 3-fold.
1. To investigate the basis for the increased content of
ALA-induced PpIX in malignant cells. Correlation
between PpIX production and cell doubling times was
examined.
2. To examine the relationship between efficacy of photo-
toxicity and PpIX content by using modulators of PpIX
synthesis and cells with varying proliferative poten-
tial.
3. To examine the intracellular localisation of PpIX by
using fluorescence microscopy, which might affect
phototoxicity.
Seven cell lines (both malignant and normal) derived from
skin and bladder were used.
Materials and umetods
Cell lines
NBT-II (rat bladder carcinoma cell line) was grown in
Eagle's minimal essential medium (MEM) with L-glutamine
(Gibco, Grand Island, NY, USA) supplemented with 10%
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fetal calf serum (FCS) (Gibco), 0.1 mM non-essential amino
acid (Gibco), I mM sodium pyruvate (Whittaker Bioproduct,
Walkersvile, MD, USA) and penicillin-streptomycin
(l00unitsmll penicilln G, 100pgml' streptomycin,
Sigma, St Louis, MO, USA). FHs738BL derived from
human fetal normal bladder was grown in DMEM with
4,500 mg 1- glucose and L-glUtanUin supplemnted with
10% FCS. HSF (human skin fibroblast cell line) was cul-
tivated in DMEM with 1,000 mg1- glucose, L-glutamine,
25mM HEPES and llOmgml-I sodium pyruvate suppl-
mented with 10% FCS. EJ derived from human transitional
cell bladder carcinoma was grown in McCoy's 5A modified
medium supplemented with 5% FCS. PAM cells (murine
squamous cell carcinoma), B16 (murine melanoma cell lne)
and A431 cells (human epidermoid carcinoma) were har-
vested in RPMI-1640 supplmented with 10% FCS and
penicillin-streptomycin. HSF was established in our
laboratory from the neonatal foreskin. EJ was kindly
donated by C.W. Lin. All other cell lines were obtained from
the American Type Culture Collection and were incubated at
37C in an atmosphere of 5% carbon dioxide and 95% air.
The cells were passaged every 4-5 days.
Chemicals
ALA, coproporphyrin (COPRO), uroporphyrin (URO),
PpIX, rhodamine 123 and 3-(4,5-dimethylthiazol-2-yl-2,5-
diphenyl tetrazolium bromide (MIT) were purchased from
Sigma. Desferal was obtained from Ciba-Geigy (Basle,
Switzerland) and verapamil from Abbott (North Chicago, IL,
USA). ALA solution was freshly made by dissolving it in
0.9% sodium chloride solution and the pH was adjusted to
7.4 using 1 M sodium hydroxide. Verapamil was dissolved in
phosphate-buffered saline (PBS). Desferal was dissolved in
distilled water.
Spectroscopy
COPRO, URO and PpIX were dissolved in methanol-water
(v/v 9:1) and the ultraviolet-visible absorbance spectra were
recorded on a Model 8451A Hewlett-Packard spectrophoto-
meter. Emission spectra were recorded on a spectrofluori-
meter (model Fluorolog 2, SPEX Industries, Edison, NJ,
USA) on samples with identical absorbance at 400 nm. The
excitation wavelength was 400nm and emission spectra were
recorded from 600 to 725 nm. In addition, cell suspension
absorbance spectra were also obtained with NBT-H and
PAM cells. A total of 1.5 x 10' NBT-II or PAM cells were
plated in 35 mm Petri dishes (P-35 dishes). Twenty-four
hours later 1 mM ALA (final concentration in medium) was
added to the cells, which were then incubated for another
24 h. Cells were then trypsinized and spun, the supernatant
discarded, the cells resusended in PBS and the spectra of
cell suspensions recorded. Cells without ALA were used for
background subtraction of the spectrum, and the number of
the cells in the solution was equalised to reduce the error
caused by scattering effects.
PpIXbiosynthesis
Seven different cell lines of human and murne origin were
used. In each experiment, 1.5 x 105 cells were plated in P-35
dishes and incubated for 24h. The cells were then placed in
fresh medium which contained 1 mM ALA and PpIX was
extracted from the cells as described below 1, 4 and 24h
later. Up-regulation of PpIX synthesis was investigated by
the addition of desferal. Desferal at a concentration of 5 or
lOgml-' was admin d with ALA to the cells to deter-
mine whether there was an increase in cellular PpIX con-
tent.
Measurement ofPpIX content
Preliminary experiments established both methanol-water
and 0.1 M sodium hydroxide - 0.1% SDS as effective agents
for extraction ofPpIX. In both cases, >90% extraction yield
was obtained for the PpIX. The methanol-water system was
chosen for all extractions in this study. Cellular content of
PpIX was detmined by fluorescence spectroscopy of the cell
extracts and comparison with standard solutions. After
incubation with ALA for various times, the medium was
removed and the cells were washed with PBS twice and
detached from the dishes with 0.1% trypsin. Cells were
suspended in PBS (total 1.0ml) and the cell suspension was
spun at 1,500 r.p.m. for 5 min. The supernatant (with vir-
tually no measurable fluorescnce) was discarded and 3 ml of
methanol-water was added to the pelet and sonicated for
15 min. After sonication, the suspension was spun at
1,500 r.pm. for 5 min, the supernatant decanted into a clear
four-sided cuvette and the fluorescence measured with the
spectrofluorimeter. The excitation wavelength was 400 nm
and the emission spectra were scanned from 600 to 725 nm.
The peak fluorescence vahle at 631 nm was used for analysis.
(A comparison with area analyses showed essentially iden-
tical results.) PpIX content was quantified by comparison
with a standard curve pirepred with known amounts of
PplX in methanol-water. Fluorescence signals were within
the linear range of the standard curve. The proten content of
the cells was measured by the Bio-Rad colorimetric assay
(Bradford, 1976). The amount of PpIX in the cells was
expressed in nglAg-' protein.
In order to esimate PpIX loss even while cells were being
incubated with ALA, PpIX content in the medium was
measured for NBT-ll cells 1, 2, 4, 6, 8, 12 and 24h after
start of ALA incubation by extraction and fluorescence spec-
troscopy. Briefly, at the end of the incubation period, the
medium was diluted 3-fold in methanol-water in a clear
four-sided cuvette and fluorescence was measured. Com-
parison was made with standard PpIX solution as in the
determination of cellular PpIX content. The appropriate
amount of culture medium was used along with methanol-
water for maing up of standard solutions. All procedures
were performed under subdued light.
Efflux experients
After incubating cells with 1 mM ALA for 4h, cells were
washed with PBS and fresh medium without ALA was added
to cells. PpIX was extracted from the cells 1, 2, 3, 4, 8 and
20 h after changing the medium in NBT-HI and EJ cells. In
addition, for NBT-H cells, PpIX content in the medium was
also measured 1, 2, 3, 4, 6, 8 and 20h after changing the
medium. For all other cells, intracellular PpIX was measured
1, 4, 8 and 20 h after anging the medium. PpIX content in
cells and medium was determined as described above. Inhibi-
tion ofverapamil-mediated PpIX efflux was investigated only
in NBT-II cells. ALA with 10 pgml-' verapamil was added
to NBT-H cells for 4 h followed by fresh medium with
verapamil alone. In a second set ofexperiments, ALA (with-
out verapamil) was added to NBT-H cells for 4 h followed by
fresh medium with verapamil. One, 4 and 20 h after medium
change, PplX content was determined as described above.
Cell doubling time
A total of I x I0W cells were plated in P-35 dishes. Cells were
detached from the dishes by trypsin and the cell number was
determined with a Coulter counter every 24 h until
confluence. Doubling time was calculated according to the
following formula (Hideki, 1988):
Doubling time = (t2-tl) log 2
log N2-N,
where N, and N2 are the cell numbers at time points t, and t2
respectively.
Fluorescence miroscopy
Intracellular locaisation of PpLX was investigated by
fluorescence microscopy. NBT-II, El and FHs738BL cellA MECHANISTIC STUDY OF ALA-INDUCED PORPHYRIN 23
lines were used for this experimnt. Cells (5 x 1O) were
plated on a coverslip. Twenty-four hours later, cells were
incubated with 1mM ALA for 1 or 4h. Fifteen minutes
before visualising the fluorescence, rhodamine 123 was added
to the culture medium at a concentration of 10#gml-'. At
completion of incubation of the two compounds, the cover-
slip was rinsed several times with PBS and viewed on an
Axiophot epi-illumination fluorescence microscope (Thorn-
wood, NY, USA) fitted with a Xibion charge-coupled device
camera (San Diego, CA, USA). For detecting PpIX
fluorescence, 400 and 630 nm bandpass filters (bandwidth
10nm) were used for excitation and emission respectively.
For rhodamine 123 detection, 480 and 510 nm bandpass
filters (bandwidth 10 nm) were used respectively. The above
combination of bandpass filters completely separated the
fluorescence signal of PpIX and rhodamine 123. The data
were digitised and transferred to a Macintosh computer for
image capture.
Photodynanic treatment
All seven cell lines were tested for phototoxic response. Cells
were plated at a concentration of 1.5 x I05 cells in P-35
dishes. Forty-eight hours later, cells were incubated with
1 mM ALA for 4 h, then washed with PBS and exposed to a
varying dose (0.2-5.OJcm-) of 514.5 nm irradiation. The
laser light was coupled into a 1 mm quartz fibre and an
appropriate spot size was created with an objective lens. The
power output from the fibre was measured with a power
meter (Coherent, Palo Alto, CA, USA) and the fluence rate
was set at 50 mWcm-'. After irradiation, cells were
incubated with fresh medium for 24h. The activity of the
mitochondrial enzyme, succinate dehydrogenase, in the 'MTT
assay' was used to assess cell cytotoxicity.
MITassay
A modified MTT assay adopted from Mosmann (1983) was
used. Briefly, after removing the medium, cells were washed
once with PBS followed by addition of 1 ml of 1.5 mgml-'
MTT dissolved in PBS and were incubated at 37C for 4 h.
The MTT solution was carefully removed and 0.5 ml di-
methylsulphoxide was added to the cells. Plates were shaken
at moderate speed (Clinical Rotator, Fisher) for 30min to
completely dissolve the formazan which was metabolically
synthesised from MTT in the mitochondria of living cells.
Fifty microlitres of the solution was transferred into a 96-
well plate and the plate was read on a ELISA reader (model
2550, Bio-RAD) using a 577 nm bandpass filter. Absorbance
of the solution from the treated cell plate was divided by
absorbance of the solution from the control cell plate (no
treatment) to calculate the fraction of survival.
Modulation ofPpIX biosynthesis and PDT
NBT-II cells were incubated with ALA alone or ALA plus
desferal for 4 and 24 h followed by 1 J cm-2 of 514.5 nm
irradiation. For 4 h incubation, drugs were added 48 h after
plating cells, and for the 24 h incubation drugs were added
24 h after plating cells so as to obtain comparable cell
numbers in both settings at the time of irradiation. Twenty-
four hours after PDT, phototoxicity was measured by the
MTT assay as above.
Electron microscopy
PAM cells were used for this experiment. After 4 h of 1 mM
ALA incubation, cells were irradiated with 3 J cm-2 of
514.5 nm light. After PDT, cells were incubated with fresh
medium for either 1 h or 20 h followed by fixation with
Karnovsky's paraformaldehyde-glutaraldehyde at room
temperature overnight. Cells were washed with 0.1 M
cacodylate buffer at 4 C and post-fixed for 1 h in 3%
osmium tetroxide, washed in distilled water and incubated in
uranyl acetate-veronal buffer (pH 7.2) at room temperature
for 4h. Following dehydration in ethanol, the cells were
embedded in Epon 812. Thin sections (0.08 pm thick) were
stained with 1% uranyl acetate and 0.25% lead citrate and
viewed with a transmission electron microscope (Yeol, JEM-
1200EX, Tokyo, Japan).
Resits
Spectroscopy
The absorption spectrum of NBT-II cell suspension with
ALA post incubation (24 h) is presented in Figure 1. There
was the expected Soret band at 412 nm followed by four
small Q bands at 506, 532, 580 and 630 rm. The absorbance
values at 514 rm and at 630 nm were similar. Identical spec-
tra were obtained with other cell lines. All PDT experiments
were carried out with 514.5 nm irradiation. Three porphyrins
(COPRO, URO and PpIX) which are intermediates in the
pathway of haem biosynthesis might be produced by exo-
genous administration ofALA. The emission spectra of these
three porphyrins in methanol-water are shown in Figure 2.
The emission peak of COPRO, URO and PpIX was 622, 625
and 631 nm respectively. (Shoulders in the spectra were noted
when mixtures of COPRO, URO and PpIX were tested.) In
this region, the emission spectrum of the cell extract gave a
single peak at 631 nm, corresponding to PpIX.
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Fuge I Absorption spectrum of PpIX in a cell suspension.
NBT-II ceLs were incubated with 1 mM ALA for 24h. The
ultraviolet-visible absorption spectrum of the cell suspension was
obtained using a Hewlett Packard spectrophotometer. Cell
suspension incubated without ALA were used as a reference.
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Ilwe 2 Emission spectrwm of porphyrins in methanol- water
(9:1, v/v). COPRO, URO and PpIX were dissolved in
methanol-water and emission spectra were obtained by spec-
trofluorimetry. The concentration of each solution was adjusted
so as to equalise the absorbance at 400rm, the excitation
wavelength. The emission peaks for COPRO (---), URO ( )
and PpIX ( in methanol- water solutions can be seen at 622,
625 and 631 rm respectively.
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PpIXbiosynthesis and cellular content ofPpIX
Cellar PpIX synthesis and the effect of desferal are sum-
marised in Table I for incubation times of 1, 4 and 24 h and
1 mM ALA. There was no measurable endogenous PpIX in
all cell lines investigated. All cells produced PpIX 1 h after
administation of 1 mM ALA and continued PpIX synthesis
to 4 h. In HSF, B16, NBT-H and EJ cell lines, PpIX content
further increased up to 24 h. Conversely, in A431, FHs738BL
and PAM cells, PpIX content at 24 h was almost the same as
the content at 4 h. In the NBT-Il cell line, there was a nearly
consistent increase of PpIX in the culture medium, and after
24 h ALA incubation, the PpIX content in the medium was
much higher than PpIX in the cells. The PpIX ratio between
cells and medium was 1:0.63 at 4h and 1:3.3 at 24h. Co-
administration of 5 Lg ml-' desferal significantly increased
cellular PpIX content in all malignant cell lines (40-50%
increase, P<0.05, Wilcoxon rank-sum test). There was no
statistically significant effect of desferal on the normal cell
lines (FHs738BL and HSF). Experiments using l0#igmll
desferal showed marked toxicity in malignant cell lines upon
24h incubation (about 75% cell death).
Efflux experiments
Four hours after incubation of 1 mM ALA, the medium was
replaced with fresh medium without ALA to evaluate the
kinetics ofPpIX efflux (Figure 3). There appeared to be three
different groups in terms of the rate of efflux. In the first
group, the bladder cancer cell lines (NBT-II and EJ cell
lines), cellular PpIX content decreased by half in 2 h. In the
second group (B16, HSF, FHs738BL and A431), the cellular
PpIX content was reduced by half in approximately 6 h. In
Time (h)
Figwe 3 Cellular efflux kinetics of PpIX. Cells were incubated
with 1 mm ALA for 4 h, then the medium was replaced with
fresh medium without ALA. Two different groups in terms of the
rates of PpIX efflux from the cells can be distinguished. Broken
lines, rapid efflux; solid lines, slow efflux; bars, s.e. At last two
sets of triplicate experiments were performed. -0- PAM;
--A--, EJ; --O--, NBT-II; -*-, B16; -A-, HSF;
-U-, FHs738BL; -*-, A431.
PAM cells, efflux was very slow and 50% reduction of PpIX
content reached at 1Oh. Of the three cell lines with the
highest uptake, two, NBT-Il and El, also had the highest
efflux. Since the two bladder cancer cell lines showed higher
efflux, we examined the effect of verapamil on one of them
(NBT-H) to test for the inhibition of efflux of cellular PpIX
through P-glycoprotein efflux pump blocking (Ling, 1992);
no enhancement of cellular PpIX content was seen (data not
shown). PpIX content in the medium was also followed for
the NBT-HI cell line. Four hours after changing the medium,
about 80% of PpIX was in the medium at time points when
cellular PpIX was negligible.
Cell doubling time
The doubling times of all cell lines and PpIX content follow-
ing 4 h and 24 h incubation with ALA are shown in Table I.
Doubling times of most of the cell lines were between 14 and
33 h. The FHs738BL cells had a long doubling time (50.5 h).
There was no general correlation between cell doubling time
and cellular PpIX content. All cell lines were in the logarith-
mic phase of growth, therefore variations in uptake due to
growth phase were not apparent as has been reported for
other sensitisers (West et al., 1990).
Fluorescence microscopy
Strong perinuclear and weak cytoplasmic and plasma mem-
brane fluorescence of ALA-induced PpIX was observed in
NBT-II and EJ cells 1 and 4 h after ALA incubation. There
was higher fluorescence intensity following 4 h incubation
with ALA (Figures 4a and 5a for NBT-H and EJ respec-
tively) than with 1 h incubation (data not shown). These
microscopic observations are consistent with the extraction
data. The PpIX fluorescence in the NBT-I1 cells was pen-
nuclear and punctate (Figure 4a), typical of a reported
mitochondrial pattern. This was confirmed with an identical
perinuclear fluorescence of rhodamine 123 seen in NBT-II
cells (Figure 4b). A phase-contrast micrograph of NBT-II
cells is presented in Figure 4c for companson. In EJ cells, a
largely perinuclear PpIX and identical rhodamine 123
fluorescence was apparent, shown in Figure 5a and b respec-
tively. For both PpIX and rhodamine 123, there appeared to
be bright spots (central and otherwise) in addition to general-
ised perinuclear fluorescence. In FHs738BL cells, very weak
fluorescence was detected after 4 h ALA incubation but none
after 1 h (data not shown). In general, the fluorescence pat-
tern of PpIX was identical to that of rhodamine 123 in all
cell lines. However, in EJ cells, there was an inverse relation-
ship in the fluorescence intensity of PpIX and rhodamine
123. Cells which contained more PpIX exhibited less intense
rhodamine fluorescence in the motochondria and vice
versa.
Photodynamic treatment
Cells were incubated with 1 mM ALA for 4 h and exposed to
varying fluence at a wavelength of 514.5 nm. A light dose-
dependent phototoxicity was observed (Figure 6). Effective
photodynamic effects were obtained in NBT-II, PAM and EJ
Table I ALA-indced PpIX synthesis and its modulation'
Doubling time Celhlar PpIX (ng Lg-' protein) (mean ± s.e.)
(h) I h 4 h 24 h 24 h (desferal) Per cent increase'
A431 23.6 ± 2.0 23.8 ± 0.9 44.0 ± 2.2 38.3 ± 1.5 54.5 ± 3.7 42*
FHs738BL 50.5 ± 3.5 30.6 ± 0.9 77.4 ± 5.0 73.3 ± 2.4 84.0 3.7 15, NS
HSF 33.4± 3.2 36.8 ± 12.5 86.8 ± 7.4 113.2 ± 6.8 124.3 6.0 10, NS
B16 15.2 ± 2.0 69.4 ± 14.1 138.9 ± 17.4 242.8 ± 28.2 335.6 ± 28.2 38*
NBT-II 15.8 ±1.8 111.7 ± 4.3 216.2 ± 8.6 286.4 ± 8.6 687.3 20.0 40*
EJ 24.5± 1.2 110.4± 12.8 253.4± 14.4 592.5± 37.4 901.7± 101.1 52*
PAM 14.3± 1.0 131.3 ± 5.9 374.6± 22.1 372.6± 19.8 565.6± 18.6 52*
aCells were incubated with I mm followed by extraction as described in Materials and methods. b[(PpIX with desferal
- PpIX without desferal)/PpIX without desferal x 100. *P <0.05 [24 h (desferal) vs 24hJ. NS, not significant. Mean
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h
Figure 4 a, Fluorescence micrograph of ALA-induced PpIX in
NBT-II cells. b, Fluorescence micrograph of rhodamine 123-
stained NBT-II cells. c, Phase-contrast micrograph of NBT-II
cells. NBT-II cells were co-stained with ALA (4 h incubation)
and rhodamine 123 and each fluorescence photomicrograph was
taken by using different filters as discussed in Materials and
methods. Scale bars represent 100 jm.
cell lines. The effects were less pronounced for the rest of the
cell lines. There was some but not a strict 1: 1 correlation
between cellular PpIX content and PDT response. There was
neither dark toxicity (ALA alone) nor light alone toxicity
(5 J cm2).
Modulation ofPpIX biosynthesis and PDT
The effect of desferal on PpIX phototoxicity was investigated
in the NBT-II cells. ALA with or without 5 jig ml-' desferal
Figure 5 a, Fluorescence micrograph of ALA-induced PpIX in
EJ cells. b, Fluorescence micrograph of rhodamine 123-stained EJ
cells. EJ cells were co-stained with ALA (4 h incubation) and
rhodamine 123, and each fluorescence photomicrograph was
taken by using different filters as discussed in Materials and
methods. Scale bars represent 100 gm.
was administered to cells for 4 and 24 h followed by 1 J cm-2
of 514.5 nm irradiation. The phototoxicity was increased
when cells were incubated with ALA and desferal as com-
pared with incubaton with ALA alone (data not shown,
P<0.05, Wilcoxon rank-sum test). When 1O ig ml-' desferal
was used, there was significant dark toxicity to all cells.
Electron microscopy
One hour after treatment with ALA-induced PDT, PAM
cells showed marked swelling of mitochondria and the loss of
cristae as compared with controls (Figure 7a and b). The cell
membrane and other subcellular organs showed little damage
compared with mitochondria. At the same light dose
(3 J cm-2) 20 h following PDT, there was extensive cell ne-
crosis, and total destruction of cell organelles was noted.
Discussion
ALA photobiology has been extensively investigated in plant
systems (Rebeiz et al., 1992). More recently, an exciting
avenue of ALA photobiology has opened up with its applica-
tion to PDT as initiated by Kennedy et al. (Pottier et al.,
1986; Malik & Lugaci, 1987; Malik et al., 1989; Divaris et
al., 1990; Kennedy et al., 1990; Bedwell et al., 1992; Loh et
al., 1992; Kennedy & Pottier, 1992; Loh et al., 1993a,b).
Kennedy's group demonstrated that topical application of
ALA to certain skin tumours, followed by PDT with red
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Fugwe 6 Light dose-dependent phototoxicity mediated by ALA-
induced PpIX in different cell lines. Cells were incubated with
I mM ALA for 4 h followed by irradiation at a wavelength of
514.5 nm. Phototoxicity was evaluated 24 h after irradiation by
the MTT assay as described. Results are expressed as survival
fraction of PDT-treated cells by comparing with untreated con-
trol cells. Bars = s.e. At least two sets of triplicate experiments
were performed -*-, A431; -A-, FHs738BL; -U-, HSF;
---*--, B16; --O--, PAM; - --, EJ; --O--, NBT-II.
light, frequently leads to the successful eradication of
tumours without damage to normal skin. This rather selec-
tive response was attributed to increased PpIX content in
tumours compared with normal skin. Bedwell et al. (1992)
demonstrated that PpIX synthesis was elevated in malignant
cells in a rat colonic tumour model after systemic administra-
tion of ALA. They measured ALA-induced PpIX by fluores-
cence microscopy and found that the fluorescnce intensity of
the tumour glands was about six times higher than normal
glands 6 h after ALA administration. The basis for the in-
creased PpIX content in skin tumours following topical ALA
application was probably a disturbed stratum corneum over-
lying tumours (Goff et al., 1992). Clearly, for PDT involving
systemic administration of ALA-induced PpIX, other deter-
minants must be important. Rebeiz et al. (1992) suggested
that cells with rapid turnover produced more PpIX. They
measured the PpIX content of spkenocytes after incubation
with ALA and 1,10-phenanthroline. Splenocytes activated by
concanavalin A produced 10-fold more PpIX than resting
splenocytes. One of the questions that our investigation
asked was whether cell proliferation rates could be a major
determinant of ALA-induced PpIX content in tumour cells.
We therefore evaluated ALA-induced PpIX production in the
malignant cell lines of both human and murine origin as well
as the normal cell lines and compared doubling times with
PpIX cellular content. Unlike the splenocyte data, doubling
times of cells did not correlate exceptionally with PpIX
biosynthesis. Although cells with high proliferative rates
often synthesised more PpIX (Table I), this was not always
true. PpIX content of A431 cell lines was the lowest among
seven cell lines despite their relatively high proliferation rates
(low doubling times). The possible explanation is that the
capacity of enzymatic conversion from porphobilinogen to
uroporphyrinogen was small, so more porphobilinogen
accumulated in the cell than PpIX. Bonkovsky et al. (1985)
suggest this process is rate-limiting when exogenous ALA is
administered to liver homogenates. The factors that affect
different enzymatic activities remain to be studied.
FHs738BL cells synthesised about the same amount of PpIX
as HSF cells despite their widely different proliferation rates.
This may be due to efficient ferrochelatase activity in most
normal cells compared with malignant cells (Hillegersberg et
al., 1992) so that, regardless of proliferation and PpIX syn-
thesis rates, the efficient conversion to haem generally main-
tained low levels of intracellular PpIX content. Cell cycle
effects may play a role in determining PpIX content,
although PpIX synthesis is reported to be largely insensitive
in relation to cell cycle in cultured mammalian epithelial cells
(Fukuda et al., 1993) in contrast to other photosensitisers
b
Fwe 7 Transmission electron micrograph of PAM ceUls. a,
Control. b, One hour after PDT (4 h incubation of 1 mM ALA,
3 J cm-2 of 514.5 nm irradiation). Note swelling of mitochondria
and loss of cristae. N. Nucleus; *mitochondrion. Scale bars repre-
sent 0.5 1m.
(West et al., 1990). However, the rate of loss of porphyrins
did show a slight dependence on cell cycle phase in the same
epithelial cells (Fukuda et al., 1993).
Desferal is an iron chelator which blocks ferrochelatase
that converts PpIX into haem. Co-administration of
5 ;g ml-' desferal and ALA significantly increased PpIX
accumulation in all carcinoma cell lines but not in normal
cell lines. Several reports showed that ferrochelatase activity
ofhepatoma tissue was lower than that of normal liver tissue
(Smith, 1987; Hillegersberg et al., 1992). It is likely that
5 lg ml1' desferal was enough to increase PpIX accumula-
tion in malignant cell lines via decreasing ferrochelatase
activity to a negligible level. In the normal cell lines, on the
other hand, there was little effect of desferal because of
relatively high ferrochelatase activity. The marked dark toxi-
city seen at 10 g ml-' desferal in cancer cell lines was
probably because at this concentration desferal blocked fer-
rochelatase activity completely and the cells died from a lack
of vital enzymes such as the cytochromes. Desferal is a
well-known therapeutic drug for acute iron poisoning (Curry,
1992). Therefore, a combination of ALA and desferal is
clinically applicable but clearly a judicious drug dose is man-
datory because of its dark toxicity.
The efflux experiments showed two distinct groups in terms
of the efflux rate. PpIX efflux is based on both diffusion and
interaction with proteins in the culture medium (Granick et
al., 1975; Fukuda et al., 1993). The difference in the rate of
efflux observed in this study cannot be explained simply by
diffusion from the cells. The cells which produced more PpIX
(NBT-II and EJ) seemed to have additional efflux mechan-
isms because, in these two cell lines, PpIX efflux was rapid.
This could also be a reflection of the origin of the cells;
malignant cells derived from the urothelium may have a
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more efficient drug efflux mechanism. In all cells, the rate of
increase of cellular PpIX either decreased or plateaued after
4 h of ALA incubation. Measurement of PpIX content in the
medium after incubation with NBT-II cells showed a con-
stant increase of PpIX throughout 24 h. The decrease in the
rate of increase of the intracellular content of PpIX is
therefore attributed to the effilux of PpIX and is consistent
with data by Fukuda et al. (1993). It is conceivable that the
decrease in the rate is the result of a lower availability of
ALA because of its reported instability in neutral and
alkaline pH (Butler & George, 1992; Loh et al., 1993a). For
NBT-II cells, PpIX content of both culture medium and cells
was measured after changing to fresh medium with no ALA.
After 4 h, 80% of the intracellular PpIX was already in the
medium with negligible cellular PpIX. This might suggest
that up to 20% of PpIX might have been converted into
haem. Therefore efflux experiments may not be exclusively
'efflux' experiments, but represent the dominant factor which
governs the decrease in intracellular PpIX.
Verapamil and other calcium channel blockers have been
investigated as inhibitors of the P-glycoprotein-related efflux
pump expressed in multidrug-resistant cell lines (Ling, 1992).
These compounds have also been suggested to be capable of
reversing porphyrin efflux (H. Diddens, personal communica-
tion). In our study, verapamil did not block PpIX efflux,
suggesting that there might be other mechanisms responsible
for PpIX efflux in bladder carcinoma cells. The absence of
P-glycoprotein mRNA was confirmed by Northern blot
analysis using mdrl probe (data not shown).
PpIX is, of course, synthesised in the mitochondria (Ken-
nedy et al., 1990). We investigated the intracellular localisa-
tion of ALA-induced PpIX by using fluorescence microscopy
since PpIX synthesis and efflux are dynamic and we did not
know which cellular compartment may be dominated by
PpIX at the time of irradiation. Although some fluorescence
was present in the cytoplasm and plasma membrane, fluores-
cence microscopy results suggest that most of the ALA-
induced PpIX did indeed localise in the mitochondria.
Furthermore, electron microscopy results confirmed early
irreversible damage of the mitochondria with no obvious
damage to other suborganelles (e.g. lysosomes, Golgi) after
PDT, suggesting that the primary cause of cell death was
mitochondrial phototoxicity, as expected. These observations
do not rule out the possibility of more subtle damage
(primarily or secondarily) to other organelles.
There was no strict correlation between PpIX cellular con-
tent and ALA-induced phototoxicity in different cell lines
(Table I and Figure 6). There seemed to be two groups in
terms of PDT efficacy; four different cell lines which synthe-
sised less than 140ng of PpIXperjig of protein (4h ALA
incubation) exhibited very little phototoxic damage, which
suggests that some threshold of cellular PpIX is required for
PDT-induced cell killing. There was no correlation between
cellular PpIX content and phototoxicity in the other cell lines
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